Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973981 · ClinicalTrials.gov registry record · NA
The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment
A NA study of Smoking, Cigarette, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 433
- Enrollment target
- 1
- Study location
NCT05973981: Completed NA study of Smoking, Cigarette, sponsored by RAND.
NCT05973981 is a NA study of Smoking, Cigarette that has completed, run by RAND. The registered enrollment target is 433 participants, below the 513-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05973981, a NA study of Smoking, Cigarette, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 433 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this research is to experimentally evaluate the extent to which partially standardizing the color of tobacco packaging influences tobacco use intentions among young adults who have varying levels of tobacco use experience.
Primary Outcome
Motivation to quit smoking as assessed by the Motivation to Stop Scale (MTSS; Kotz et al., 2013; Drug and Alcohol Dependence) participants endorsing one of 7 items: 1. = I don't want to stop smoking. 2. = I think I should stop smoking but don't really want to. 3. = I want to stop smoking but haven't thought about when. 4. = I REALLY want to stop smoking but I don't know when I will. 5. = I want to stop smoking and hope to soon. 6. = I REALLY want to stop smoking and intend to in the next 3 mont
Conditions Studied
Interventions
- BEHAVIORAL Package standardization
Study Locations (1)
Pennsylvania
- RAND Corporation - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 433 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2025-05-14 |
| Phase | NA |
What the finished NCT05973981 record still lists
NCT05973981 is an interventional study that assigns participants to a tested intervention. The registered 433 participants enrollment target is mid-sized for trials with a published cap, below the 513-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (16% lower).
The record links to 1 condition, with Smoking, Cigarette appearing as the primary indexed condition, and to 1 intervention - of which Package standardization is the first listed.
NCT05973981 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05973981 about?
NCT05973981 is a clinical study titled "The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment". The overall aim of this research is to experimentally evaluate the extent to which partially standardizing the color of tobacco packaging influences tobacco use intentions among young adults who have varying levels of tobacco use experience.
What is the current status of trial NCT05973981?
This trial is currently completed. It is a NA study. The enrollment target is 433 participants. The study started on 2023-05-15. Estimated completion is 2025-05-14.
What conditions does trial NCT05973981 study?
This clinical trial studies the following conditions: Smoking, Cigarette.
What interventions are being tested in trial NCT05973981?
The interventions under investigation include: Package standardization (BEHAVIORAL).
Who is sponsoring clinical trial NCT05973981?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973981 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking, Cigarette
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05973981's enrollment target sits among peer trials
433 6th of 21 higher than 16 of 21 other Smoking, Cigarette trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking, Cigarette trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
RECRUITING · NA
-
Optimizing Tobacco Treatment Delivery for People Living With HIV
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
Maternal Smoking Cessation and Pediatric Obesity Prevention
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI